I felt Evelyn’s crumpled note warm in my palm, the paper thin as a secret.
“You know what to do,” it read, the ink smudged by the flickering hallway light.
My mind raced back to the night Alex slipped out of the ER, his coat still on his shoulders, his phone glowing with a call I’d missed.
When the lights sputtered back, a new call cut through the darkness—Alex’s investor, Marco, his voice sharp as a scalpel.
“Maya, we need an answer by morning. Either we push the trial forward or we pull the plug. No middle ground.”
The words slammed into me like a wave.
My throat tightened; I could taste metal and fear.
What was Alex hiding? The note hinted at a biotech startup—his, perhaps—a venture that promised to rewrite fevers, to cure the very thing now burning through our daughter’s skin.
My thoughts collided: protect the baby now, or gamble on a future that might save countless lives.
“Alex,” I whispered, half to the empty hallway, half to the darkness, “what are you really doing?”
Confrontation and Collapse
Alex’s shoulders slumped when I finally pulled him aside, his eyes darting between the dim monitors and the empty chair where his mother’s stare still lingered.
“I forged the trial,” he confessed, voice barely audible over the emergency hum.
“We tried a therapy that could drop a fever in minutes. It was supposed to be our miracle.”
He swallowed, the weight of his sister’s failed trial pressing down like a stone.
“When it blew up, the scandal ruined everything. Evelyn—my mother—couldn’t stand the shame. She’s been trying to keep me from the fallout.”
My heart hammered, each beat echoing the baby’s shallow breaths.
“Do you think we can still use it? On our daughter?” I asked, the question a knife.
Alex’s gaze hardened, the resolve of a man who’d built a company on hope and desperation.
“If it works, it could save her now. If it fails… we lose everything.”
Just then the backup generators coughed to life; the ceiling lights flickered back on, harsh and unforgiving.
The monitor beside our baby erupted in a frantic series of beeps, each tone rising higher, a scream of alarms.
My breath caught; the screen flashed red, the temperature spiking beyond what any chart could justify.
In that instant, Marco’s voice rang in my ears—“Decide, or we pull the funding.”
The room spun, the beeping relentless, as I stared at the life‑supporting display, knowing the next choice could end us all.
Dr. Patel’s Revelation
Dr. Patel stepped out of the dim hallway, his face lit by the flickering fluorescents, and asked us to follow him into the private consult room.
“Your daughter’s fever isn’t just a viral spike,” he said, eyes never leaving the monitor. “It’s a rare infection—Mycobacterium vaccinis—that’s been linked to a contaminated batch of a pediatric vaccine.”
My heart seized. “Which vaccine?” I asked, voice trembling.
He spread a thin sheet of paper across the desk, the label printed in stark black: VaxPro™—Phase II Trial. “Your baby received the lot that was just cleared for distribution two weeks ago. The contamination was identified in a regulatory notice that never made it past the internal review.”
Alex sank into the chair, his hands clenching and unclenching. “That’s my company’s trial,” he whispered, a cold sweat forming on his brow.
